Macular degeneration is one of the leading causes of vision loss, affecting millions worldwide, especially those over 60.
Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the ...
The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular ...
Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...
Signs and symptoms of age-related macular degeneration (AMD) are important to spot to prevent further deterioration of sight.
Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...
DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...
Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...
Medications for glaucoma usually come in the form of medicated eye drops. Macular degeneration is an incurable eye disease in which the central portion of the retina, the macula, deteriorates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results